Open access
Jul 2026
NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer
NOD1/2 is defined as a novel innate immune checkpoint that orchestrates therapy-induced adaptive resistance and highlight this pathway as a promising target to overcome treatment resistance in refractory cancers.
Xi-Duan Wei, Li Yang, Yuting Wang et al.
· Signal Transduction and Targ... · 0 citations